| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $30.9M | +36.8% |
| R&D Expense | $85.5M | -9.6% |
| SG&A Expense | $27.6M | -2.9% |
| Operating Income | -$86.4M | +15.9% |
| Income Tax | $0 | — |
| Net Income | -$74.3M | +14.2% |
| EPS (Basic) | -$1.18 | +25.3% |
| EPS (Diluted) | -$1.18 | +25.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $80.9M | +45.8% |
| Current Assets | $163.2M | -34.6% |
| Total Assets | $198.1M | -30.2% |
| Current Liabilities | $59.7M | -10.8% |
| Total Liabilities | $306.6M | -7.0% |
| Stockholders' Equity | -$108.5M | -138.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$86.1M | +14.2% |
| Capital Expenditures | $50K | -94.5% |
| Investing Cash Flow | $112.0M | +474.7% |
| Financing Cash Flow | $1.0M | -99.0% |
| Free Cash Flow | -$86.1M | +15.0% |